Penserra Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Penserra Capital Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,892	Closed	-$10K	–	1281
2022 Q2	$10K	Buy	1,892 +171	+10%	+$1.4K	﹤0.01%	1260
2022 Q1	$25K	Buy	1,721 +90	+6%	+$1.21K	﹤0.01%	1204
2021 Q4	$25K	Sell	1,631 -874	-35%	-$21K	﹤0.01%	1206
2021 Q3	$80K	Sell	2,505 -3,043	-55%	-$107K	﹤0.01%	900
2021 Q2	$230K	Sell	5,548 -1,781	-24%	-$73.2K	﹤0.01%	614
2021 Q1	$372K	Sell	7,329 -8,417	-53%	-$440K	0.01%	508
2020 Q4	$510K	Buy	+15,746	New	+$223K	0.01%	380

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIA

Avalon Investment & Advisory Houston, Texas $3.65B AUM 0.47% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Penserra Capital Management's DMTK Position: Q3 2022 in Review

Penserra Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2022, closing a stake of 1,892 shares — an estimated $10K sold.

Penserra Capital Management first reported a position in DMTK in Q4 2020 and held it in 7 quarters. The position peaked at $510K in Q4 2020. 127 funds tracked by Wall St. Rank hold DMTK as of Q3 2022.

Penserra Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Penserra Capital Management sold 1,892 DermTech, Inc. Common Stock shares in Q3 2022, an estimated $10K.
Penserra Capital Management first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
Penserra Capital Management's DermTech, Inc. Common Stock position peaked at $510K in Q4 2020.
127 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.